Finance

Lists
RANI:NASDAQ
Rani Therapeutics Holdings Inc
0,53 $
+0,21%
(+0,0011) 1D
13 նոյ, 16:00:00 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RANI...
Open
0,52 $
High
0,54 $
Low
0,50 $
Mkt. cap
73,40 մլն
Avg. vol.
523,18 հզր
Volume
552,87 հզր
52-wk high
1,99 $
52-wk low
0,50 $
EPS
-0,19 $
Beta
0,61
Shares outstanding
115,42 մլն
No. of employees
70
Open
0,52 $
High
0,54 $
Low
0,50 $
Mkt. cap
73,40 մլն
Avg. vol.
523,18 հզր
Volume
552,87 հզր
52-wk high
1,99 $
52-wk low
0,50 $
EPS
-0,19 $
Beta
0,61
Shares outstanding
115,42 մլն
No. of employees
70
News stories
From web sources and news partners
About Rani Therapeutics Holdings Inc
CEO-
Employees70
Founded2012
HeadquartersՍան Խոսե, Կալիֆոռնիա, Միացյալ Նահանգներ
SectorHealth Care
Industry-
Websiteranitherapeutics.com
Analyst ratings
Based on 4 analysts giving stock ratings to RANI in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for RANI in the last 3 months.
Highest
Current 0,53 $
11,00 $ (+1 990,06%)
Average
6,75 $ (+1 182,54%)
Lowest
5,00 $ (+850,03%)
Analyst
Recommendation
Action
Price target
Projected
Date
Edward Nash
Canaccord Genuity
Buy
Maintained
5,00 $
+850%
11/09/2026
Michael Okunewitch
Maxim Group
Buy
Maintained
5,00 $
+850%
11/10/2026
Brandon Folkes
H.C. Wainwright
Buy
Reiterated
11,00 $
+1 990,1%
10/06/2026
Andreas Argyrides
Chardan Capital
Buy
Initiated
6,00 $
+1 040%
08/18/2026
Daniel Brims
Lake Street
Buy
Reiterated
9,00 $
+1 610,1%
05/18/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
2026 թ. սեպ
Revenue
1,46 մլն
1,71 մլն
1,71 մլն
1,71 մլն
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4,91 մլն
5,16 մլն
5,02 մլն
6,02 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,09 մլն
4,89 մլն
5,52 մլն
4,91 մլն
Operating expense
10,00 մլն
10,05 մլն
10,54 մլն
10,93 մլն
Total operating expenses
10,00 մլն
10,05 մլն
10,54 մլն
10,93 մլն
Operating income
-8,54 մլն
-8,34 մլն
-8,83 մլն
-9,22 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-9,07 մլն
-8,02 մլն
-8,42 մլն
-8,81 մլն
EBT excluding unusual items
-8,50 մլն
-8,02 մլն
-8,42 մլն
-8,81 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-10,30 մլն
-7,03 մլն
-7,39 մլն
-7,73 մլն
Net profit margin
-705,34%
-411,77%
-432,73%
-452,78%
Earnings per share
-0,07
-0,04
-0,04
-0,04
Interest and investment income
384,00 հզր
412,00 հզր
415,00 հզր
460,00 հզր
Interest expense
-347,00 հզր
-88,00 հզր
-8,00 հզր
-43,00 հզր
Net interest expenses
37,00 հզր
324,00 հզր
407,00 հզր
417,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-8,35 մլն
-8,18 մլն
-8,68 մլն
-9,10 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps